VAFNX
Price
$34.19
Change
+$0.16 (+0.47%)
Updated
Jul 28 closing price
Net Assets
17.64B
VIGAX
Price
$234.68
Change
+$0.94 (+0.40%)
Updated
Jul 28 closing price
Net Assets
311.95B
Interact to see
Advertisement

VAFNX vs VIGAX

Header iconVAFNX vs VIGAX Comparison
Open Charts VAFNX vs VIGAXBanner chart's image
Invesco American Franchise R5
Price$34.19
Change+$0.16 (+0.47%)
VolumeN/A
Net Assets17.64B
Vanguard Growth Index Admiral
Price$234.68
Change+$0.94 (+0.40%)
VolumeN/A
Net Assets311.95B
VAFNX vs VIGAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VAFNX vs. VIGAX commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VAFNX is a Buy and VIGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 312B vs. VAFNX (17.6B). VIGAX pays higher dividends than VAFNX: VIGAX (0.45) vs VAFNX (0.00). VAFNX was incepted earlier than VIGAX: VAFNX (15 years) vs VIGAX (25 years). VAFNX (0.70) is less costly to investors than VIGAX (0.05). VAFNX is a more actively managed with annual turnover of: 51.00 vs. VIGAX (11.00). VIGAX has a lower initial minimum investment than VAFNX: VIGAX (3000) vs VAFNX (1000000). VIGAX annual gain was more profitable for investors over the last year : 26.05 vs. VAFNX (21.03). VIGAX return over 5 years is better than : 113.30 vs. VAFNX (25.56).
VAFNXVIGAXVAFNX / VIGAX
Total Expense Ratio0.700.051,400%
Annual Report Gross Expense Ratio0.700.051,400%
Fund Existence15 years25 years-
Gain YTD8.95511.10781%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets17.6B312B6%
Annual Yield % from dividends0.000.45-
Returns for 1 year21.0326.0581%
Returns for 3 years63.9880.9779%
Returns for 5 years25.56113.3023%
Returns for 10 years92.51314.4429%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMVP1.510.10
+7.09%
PMV Pharmaceuticals
CSTM13.930.26
+1.90%
Constellium SE
CMPX3.200.02
+0.63%
Compass Therapeutics
ASND164.16-3.31
-1.98%
Ascendis Pharma A/S
ALZN2.77-0.19
-6.42%
Alzamend Neuro Inc.